biologic

Humulin R U-100

insulin human

Loss of exclusivityOctober 1994projected — 12-year biologic exclusivity estimate
CompanyEli Lilly and Company

Drug detail

Brand nameHumulin R U-100
Active ingredientinsulin human
Strength1,000UNITS/10ML (100UNITS/ML)
Dosage formInjection
RouteSubcutaneous
ModalityBiologic
FDA approvalOctober 1982
Marketing statusOTC

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.

Humulin R U-100 patent cliff — loss of exclusivity October 1994 | CliffBio